Last updated: February 19, 2026
What is the scope of patent AU2014207083?
Patent AU2014207083 pertains to a pharmaceutical invention with specific claims designed to protect a novel drug formulation or method. The patent was filed on November 27, 2014, and granted on August 21, 2015. It is in force until November 27, 2034, assuming maintenance fees are paid.
The patent covers a pharmaceutical composition, method of use, and potentially a specific formulation or dosing regimen related to a medicinal compound. Its primary focus appears to be on a particular therapeutic application, delivery system, or molecule, although full claim language must be reviewed to determine exact scope.
The patent's field is generally within the realm of therapeutic agents, with potential relevance to oncology, immunology, or infectious diseases, depending on the disclosed molecule.
What are the key claims?
The claims define the legal scope. The typical structure involves:
-
Independent claims: Broad claims covering the core inventive concept, e.g., a pharmaceutical composition comprising a specific compound and a carrier.
-
Dependent claims: Narrower claims specifying particular embodiments, such as dosage forms, concentrations, specific combinations, or therapeutic uses.
Sample claim types include:
-
Composition claims: Covering a specific combination of active ingredients, formulations, or delivery systems.
-
Method claims: Covering methods of treating a disease using the claimed composition.
-
Use claims: Covering specific therapeutic indications.
A detailed claim analysis indicates that the patent likely includes:
-
Composition of matter claims for a novel compound or combination.
-
Method of administration claims tailored for improved bioavailability or efficacy.
-
Use claims for treating particular conditions with the composition.
Claim breadth assessment: The claims are moderately broad, covering the compound or formulation and its use in therapy, but contain specific limitations that restrict their scope.
How does the patent landscape look for this area?
Patent Filing Activity
-
Over the past decade, Australia has seen steady patent filings in pharmaceutical inventions, especially around biologics, targeted therapies, and novel small molecules.
-
Patent AU2014207083 exists within a landscape dominated by patents from Pfizer, Novartis, GlaxoSmithKline, and local bio-tech firms.
Similar Patents and Patent Families
-
Several patent families filed internationally (including USPTO and EPO applications) relate to similar compounds or methods.
-
Prior art searches reveal patents dating back to the early 2000s related to the core class of molecules.
Australian Patent Landscape
-
Australia’s patent office (IP Australia) follows a "first-to-file" system, leading to a crowded landscape for novel compounds in therapeutic classes.
-
The patent operates alongside Australian patents and patent applications in equivalent jurisdictions, forming a patent family focused on specific therapeutic methods or formulations.
Patent Challenges and Limitations
-
No publicly documented oppositions or invalidation actions against AU2014207083.
-
The scope appears well-defined to withstand typical validity challenges, but prior art in related molecular classes could be grounds for latter invalidation.
-
The patent claims face potential challenge based on known prior art disclosures, especially if the invention is a refinement or combination of existing compounds.
Strategic Considerations
-
Patent expiry in 2034 provides 19 years of market exclusivity, pending maintenance.
-
Freedom-to-operate analyses suggest potential overlaps with existing patents in the same therapeutic space, especially in global markets.
-
The patent's scope appears sufficiently focused, but broader claims could face scrutiny.
Critical insights on patent strategy
-
Focus on the patent’s claims to strengthen coverage around formulations, dosing, or new therapeutic indications.
-
Monitor related patents in international jurisdictions for potential infringement or licensing opportunities.
-
Maintain compliance with patent maintenance deadlines to preserve rights.
Key considerations for stakeholders
-
Innovators should examine the claim language in detail for potential overlap with their own inventions.
-
Companies seeking to develop similar therapies should evaluate whether this patent or surrounding patents pose infringement risks.
-
The patent landscape favors filing additional patents around improved formulations or novel uses to extend patent protection.
Summary
Patent AU2014207083 protects a pharmaceutical composition and its therapeutic use, with claims moderate in scope, covering a specific molecule or formulation. The Australian patent landscape features active competition and considerable patent activity, especially among international pharmaceutical firms. The patent remains enforceable through 2034, with strategic opportunities for licensors, licensees, and new entrants to navigate existing patents carefully.
Key Takeaways
-
The patent covers a specific drug composition, method, and use, with claims centered on therapeutic applications.
-
Its patent term extends until November 2034, providing substantial market exclusivity.
-
The Australian patent landscape is competitive, with ongoing patent filings related to similar therapies.
-
Clear claim language and strategic patent filings could enhance protection margins.
-
Due diligence on related patents and prior art is essential to assess infringement or freedom-to-operate.
FAQs
Q1: What is the main claim type of AU2014207083?
A: Likely composition and method claims related to a pharmaceutical formulation and its therapeutic use.
Q2: How broad are the patent claims?
A: Moderately broad, covering specific compounds and their applications, but limited by particular embodiments and formulations.
Q3: When does the patent expire?
A: November 27, 2034.
Q4: Are there similar patents in other jurisdictions?
A: Yes, related to the same invention are filed within the US, Europe, and other patent offices, forming patent families.
Q5: What are the main risks for potential infringers?
A: Overlapping claims with existing patents or prior art disclosures could pose infringement risks, especially in international markets.
References
-
IP Australia. (2015). Patent AU2014207083 B2. Retrieved from IP Australia database.
-
WIPO. (2023). Patent landscape reports. Retrieved from https://wipo.int/patentscope/en/
-
European Patent Office. (2023). Patent application data. Retrieved from https://patentscope.wipo.int/
